Delic Labs is a Canadian company based in Vancouver with a focus on chemical process development, analytical testing, and extraction optimization. The company was initially founded in 2018 by Dr. Markus Roggen and Prof. Dr. Glenn Sammis and rebranded after being sold to the DELIC Group. Since its inception, the company has focused on improving the cannabis and psilocybin industry through collaborative research and fundamental science. For more information on Delic Labs, click here. JK-Consulting_Delic-Labs_Cooperation_2022 Download the article as PDF

The Lindner Group is one of the leading companies worldwide for the building envelope, interior fit-out and insulation. Its comprehensive range of disciplines as a full-service provider for nearly all applications is unique.  Lindner SE | Clean Rooms is an internationally established full-service contractor for clean rooms, laboratories and operating theatres. We realise projects in the areas of pharmaceutical, sterile and hospital environment (ICUs, OTs etc.), microelectronics and semiconductor production around the world.  With this new partnership, we bring together

We are very pleased to announce another new partnership with ZEE GmbH. ZEE GmbH is a German provider of zero-emission energy systems that can be used to generate electrical and thermal green energy from agricultural by-products. ZEE stands for an efficient, clean, versatile and robust solution with a fast ROI and long lifetime. With this new partnership, we bring together an innovative manufacturer and the cGxP experts – and our customers benefit from a well-rounded service portfolio. For more information

from von Rainer Krüger und Dr. Lisann Eßer, J&K Consulting High demand and supposedly large profits are bringing more and more manufacturers of cannabis medicines onto the market. But can the products on offer provide the required quality? Since cannabis is to be sold in Germany as a pharmaceutical product, its production is regulated by the German Medicines Act and the Good Manufacturing Practice (GMP) guidelines. The guidelines aim to ensure the production of pharmaceutical products of consistent and high quality. However, product recalls in Canada are

from von Rainer Krüger und Dr. Lisann Eßer, J&K Consulting The prescription of medicinal cannabis in Germany has been rising constantly in the last few years, which means that both the demand and the market are growing equally. However, medicinal cannabis is a drug whose active ingredient composition and concentration depend on the genetics of the plant and thus also achieve a different effect on the patient based on the genetics. By sequencing the genomes and comparing the sequences of

from von Rainer Krüger und Dr. Lisann Eßer, J&K Consulting Medicinal cannabis is being used more and more frequently as a form of therapy, which is why the demand in Germany is growing constantly. Producers are faced with the challenge not only of meeting the high demand, but also of ensuring the highest quality while complying with regulatory requirements. As in numerous economic sectors, digitalization is targeted as a solution to current and future problems by the cannabis industry. The

from Marguerite Arnold Germany is the top target market for cannabis companies globally, but where your cultivator or distributor is located, especially in the realm of API standards, can make all the difference. Destination Germany is the watchword for those in the international cannabis industry—but it is still a rocky path to gaining access for most. Specifically, there is a lot of confusion surrounding API and cannabis classification and issues from a lack of consistent standards. One of the most intriguing aspects

from Johnny Green  Cannabis is medicine. That is a phrase that has always been true, yet was not always reflected in public policy. The cannabis plant was prohibited across the globe for many years and subjected to a tremendous amount of negative propaganda and stigma. Fortunately, the truth about the cannabis plant and its wellness properties could not be contained forever. Activists across the planet worked extremely hard to cut through the propaganda and get the facts out to society

Interview with Rainer Krüger, Co-Founder of the European Cannabis Association (german) Medicinal-Cannabis-Regelung-dringend-noetig-vom-14.12.2020 Did we arouse your interest and you would like to have further information? We gladly be available for you. You can reach us through our contact page.

Interview with Rainer Krüger, CEO of J&K Consulting (german) GMP-Compliance-Beratung-vom-14.12.2020 Did we arouse your interest and you would like to have further information? We gladly be available for you. You can reach us through our contact page.

Cannabidiol, or CBD for short, is an active ingredient of the hemp plant. It is said to help against inflammation, promote sleep and relieve anxiety. However, there have hardly been any reliable medical studies so far. Read the complete article by Angelika Friedl (german). Kleiner-Effekt-oder-grose-Wirkung_Bild-der-Wissenschaft_Juli_2020_Seite_86-88 Did we arouse your interest and you would like to have further information? We gladly be available for you. You can reach us through our contact page.

End-to-end solutions and the intelligent networking of digital twins are the beginning of one of the biggest industrial changes since industrialisation. But technological changes are not the only challenge. Read the complete article by Rainer Krüger, CEO J&K Group (german). transkript_01-2020_JK_Digitale-Lösungen Did we arouse your interest and you would like to have further information? We gladly be available for you. You can reach us through our contact page.

Increased data integrity and consistent data management with the object-orientation of COMOS. Siemens_CVal_Flyer_en Did we arouse your interest and you would like to have further information? We gladly be available for you. You can reach us through our contact page.

Read our latest article from PharmaTEC | Edition 3/4 2020 (german). Artikel-PharmaTec-Oktober-2020 Did we arouse your interest and you would like to have further information? We gladly be available for you. You can reach us through our contact page.

Read our latest article from European Biotechnology | Spring Edition | Vol. 19 | 2020 A challenge whose success lies in efficient process management and digital development! The times of digitalisation and Industry 4.0 do not stop at the production of medical cannabis for the pharmaceutical industry. The combination of IT-systems and blockchain-based processes allows the value-added chain to be automated and the data generated to be mapped in a tamper-proof manner. by Hannah Maria Lambertz, Consultant und Quality Manager

Read our latest article from European Biotechnology | Autumn Edition | Vol. 19 | 2020 Rainer Krüger, European Cannabis Association and CEO of J&K Consulting GmbH, explains how product and process standards for medical cannabis can be set. EB_Autumn_2020-ECA-Interview-mit-Cover Did we arouse your interest and you would like to have further information? We gladly be available for you. You can reach us through our contact page.

A MABEWO delegation led by CEO Jörg Trübl visited Malta in mid-July to present the project of a pharmaceutical dome on site at “Malta Enterprise”. Malta Enterprise is the local agency for economic development and foreign direct investments and therefore the first contact for MABEWO AG for project approval. The delegation was received by Mr. Kurt Farruga, Managing Director of Malta Enterprise, and the Minister of Health, Hon. Deo Debattista. Read the complete MABEWO newsletter with interview by Rainer Krüger

Feel free to read our newest article in the transkript 01.2020. If you like to read the whole magazine, click the following link: https://transkript.de/zeitschrift/ausgaben/2020.html JuK-Artikel-Transktipt Did we arouse your interest and you would like to have further information? We gladly be available for you. You can reach us through our contact page.

We are proud to announce, that we are founding members of the European Cannabis Association. The European Cannabis Association is an association of companies that promote the development of appropriate and consistent standards to support the cultivation, processing and distribution of medical cannabis in Europe. Visit the ECA-Website Did we arouse your interest and you would like to have further information? We gladly be available for you. You can reach us through our contact page.